Greiner Bio-One North America, Inc. has recalled 504,000 Greiner BIO-ONE VACUETTE 2 ml 9NC Coagulation sodium citrate 3.2% blood collection tubes. The labels on these tubes were applied too high, causing the printed fill level mark to be shifted upward. This defect can lead to laboratory staff incorrectly rejecting blood samples as underfilled, which then requires patients to undergo repeat blood collections.
Because the fill mark is incorrectly placed, medical professionals may believe a tube is underfilled even when it contains the correct volume of blood. This results in unnecessary sample rejection and the need for additional, avoidable blood draws for the patient.
Quantity: 504,000 units affected.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.